NEW ORLEANS – During the first nine months of the COVID-19 pandemic, pediatric cancer patients from lower- and middle-income...
NEW ORLEANS – A variant of the CTLA-4 gene associated with autoimmune disease was found to be more frequent...
An mRNA vaccine was combined with CAR T cells that target tumor cells expressing the CLDN6 antigen NEW ORLEANS...
Patients with recurrent lesions genetically distinct from the primary tumor may require different treatment NEW ORLEANS – More than...
NEW ORLEANS – Natural killer (NK) cells derived from cord blood that were activated and complexed with a CD30/CD16A...
Two-year follow up of the CodeBreaK 100 clinical trial demonstrated prolonged tumor responses and a favorable safety profile NEW...
NEW ORLEANS – Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination...
NEW ORLEANS – An artificial intelligence (AI) model trained using sequential health information derived from electronic health records identified...
SAN ANTONIO – Among patients with previously treated HER2-positive metastatic breast cancer, those who received pyrotinib plus capecitabine had...
Mutations were detected via circulating tumor DNA before disease progression in patients treated with an aromatase inhibitor/palbociclib for hormone...